Project: Biomarker Guided Prostate Cancer Management
| Acronym | BioGuidePCa (Reference Number: 11023) |
| Duration | 01/07/2017 |
| Project Topic | The BioGuidePCa project is designed to address the European Market demand for a diagnostic test which enables distinguishing between insignificant and significant prostate cancer (PCa). The proposed test detects peptides indicative of PCa by capillary electrophoresis-mass spectrometry (CE-MS). The output of the project will be a non-invasive test, called the “PCa Status Test”, designed to guide the treatment decision-making for patients on active surveillance. This is not a clinical study. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 6 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Mosaiques Diagnostics GmbH | Coordinator | Germany |
| 2 | Medizinische Universität Innsbruck | Partner | Austria |
| 3 | Universitätsklinikum Schleswig-Holstein | Partner | Germany |